Human papillomavirus (HPV) DNA-based tests are more accurate than cytology (Pap smears) in detecting cervical precancerous lesions, according to data from a randomized controlled trial.

A tattoo can be more than just a fashion statement – it has potential medical value, according to an article published in the online open access journal, Genetic Vaccines and Therapy.

For the first time researchers from Pennsylvania State University College of Medicine suggest a direct interaction between cigarette smoke carcinogens and the human papillomavirus that may lead to increased risk of cervical cancer. They report their findings in the January 2008 issue of the Journal of Virology.

New Brown University research shows that alcohol and tobacco use doesn’t increase the risk of cancers of the mouth and throat for people infected with human papillo-mavirus 16 (HPV16), a common sexually transmitted virus in the U.S. The findings are the strongest evidence yet that head and neck cancers have two distinct causes and may require different prevention and treatment methods.

A new vaccine against nine of the most harmful strains of human papillomavirus is under study at the Medical College of Georgia.

Canadians would welcome a vaccine against the human papillomavirus (HPV) if it were introduced at no charge, a Quebec, Canada survey suggests. Research published in the open access online journal BMC Public Health shows that 91% of young women (18-25 year-olds) would agree to vaccination, and that 89% of men and women would recommend it to their daughters or nieces

A new study led by McGill University researchers shows that the human papillomavirus (HPV) screening test is far more accurate than the traditional Pap test in detecting cervical cancer.

The routine vaccination of children against Human Papilloma Virus (HPV) - the first adolescent vaccine against a sexually transmitted infection - will be discussed at the National Cancer Research Institute conference in Birmingham today (1515hrs, Tuesday 2 October).

The Human Papillomavirus (HPV) is considered the cause of one of the most important sexually transmitted diseases nowadays, and affects both men and women. HPV is so common in our society that only people who have never had sexual relations can be sure that they have not been exposed to this disease.

Despite recommendations for annual preventive exams for adolescents, only 10 percent of teens have enough visits within 12 months to receive the recommended three shots needed for HPV vaccine. Ideally the three shots are delivered within six months, and only 1 percent of teens see their physicians that often.

The Centers for Disease Control report that nearly 25 million women are infected with some form of the Human Papilloma Virus (HPV). Of those, more than three million are thought to have one of the four strains known to cause cases of cervical cancer and genital warts.

In this Research letter, Dr. Gina Ogilvie and colleagues investigate the feasibility of self-collection of specimens for HPV testing among women who may not make full use of cytology screening programs (e.g., women who are homeless or who are involved in the sex trade) and are thus at increased risk of cervical cancer.